Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/61481

TitleMagnetoliposomes containing calcium ferrite nanoparticles for applications in breast cancer therapy
Author(s)Pereira, Daniela S. M.
Cardoso, Beatriz D.
Rodrigues, Ana Rita O.
Amorim, Carlos O.
Amaral, Vítor S.
Almeida, B. G.
Queiroz, Maria João R. P.
Martinho, Olga
Baltazar, Fátima
Calhelha, Ricardo C.
Ferreira, Isabel C. F. R.
Coutinho, Paulo J. G.
Castanheira, Elisabete M. S.
Keywordscalcium ferrite nanoparticles
magnetoliposomes
new antitumor drugs
thienopyridine derivatives
breast cancer therapy
Issue date2019
PublisherMultidisciplinary Digital Publishing Institute
JournalPharmaceutics
CitationPereira, D.S.M.; Cardoso, B.D.; Rodrigues, A.R.O.; Amorim, C.O.; Amaral, V.S.; Almeida, B.G.; Queiroz, M.-J.; Martinho, O.; Baltazar, F.; Calhelha, R.C.; Ferreira, I.C.F.R.; Coutinho, P.J.G.; Castanheira, E.M.S. Magnetoliposomes Containing Calcium Ferrite Nanoparticles for Applications in Breast Cancer Therapy. Pharmaceutics 2019, 11, 477.
Abstract(s)Magnetoliposomes containing calcium ferrite (CaFe<sub>2</sub>O<sub>4</sub>) nanoparticles were developed and characterized for the first time. CaFe<sub>2</sub>O<sub>4 </sub>nanoparticles were covered by a lipid bilayer or entrapped in liposomes forming, respectively, solid or aqueous magnetoliposomes as nanocarriers for new antitumor drugs. The magnetic nanoparticles were characterized by UV/Visible absorption, XRD, HR-TEM, and SQUID, exhibiting sizes of 5.2 ± 1.2 nm (from TEM) and a superparamagnetic behavior. The magnetoliposomes were characterized by DLS and TEM. The incorporation of two new potential antitumor drugs (thienopyridine derivatives) specifically active against breast cancer in these nanosystems was investigated by fluorescence emission and anisotropy. Aqueous magnetoliposomes, with hydrodynamic diameters around 130 nm, and solid magnetoliposomes with sizes of ca. 170 nm, interact with biomembranes by fusion and are able to transport the antitumor drugs with generally high encapsulation efficiencies (70%). These fully biocompatible drug-loaded magnetoliposomes can be promising as therapeutic agents in future applications of combined breast cancer therapy.
TypeArticle
URIhttp://hdl.handle.net/1822/61481
DOI10.3390/pharmaceutics11090477
ISSN1999-4923
Publisher versionhttps://www.mdpi.com/1999-4923/11/9/477
Peer-Reviewedyes
AccessOpen access
Appears in Collections:PHYSICS OF QUANTUM MATERIALS AND BIONANOSTRUCTURES (2018 - ...)
CDQuim - Artigos (Papers)
ICVS - Artigos em Revistas Internacionais com Referee

Files in This Item:
File Description SizeFormat 
pharmaceutics-11-00477-v2.pdf3,64 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID